Pulmonary Impact of Sodium-glucose Cotransporter-2 Inhibitors in Patients With Chronic Obstructive Pulmonary Disease Receiving Single-inhaler Triple Therapy
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
American Journal of Respiratory and Critical Care Medicine
Conference Name
American Thoracic Society (ATS) International Conference
Conference Date
2025-05-16 - 2025-05-21
First Page
A7382
DOI
10.1164/ajrccm.2025.211.Abstracts.A7382
Volume
211
Publication Date
5-1-2025
Recommended Citation
Wang, T. H., Xanthavanij, N., Lee, Y. C., Frankish, L., Peng, C., Ahmed, O., Bliss, A., Ong, T. E., Chang, K. Y., & See, X. (2025). Pulmonary Impact of Sodium-glucose Cotransporter-2 Inhibitors in Patients With Chronic Obstructive Pulmonary Disease Receiving Single-inhaler Triple Therapy. American Journal of Respiratory and Critical Care Medicine, 211, A7382. https://doi.org/10.1164/ajrccm.2025.211.Abstracts.A7382